Page last updated: 2024-08-21

thiazoles and biguanides

thiazoles has been researched along with biguanides in 38 studies

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19902 (5.26)18.7374
1990's9 (23.68)18.2507
2000's25 (65.79)29.6817
2010's2 (5.26)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barker, J; Brown, MR; Collier, PJ; Farrell, I; Gilbert, P1
Rosskamp, E1
Basu, UP; Bose, AN; Ghosh, SN1
van Haeften, TW; Wolffenbuttel, BH1
Melander, A1
Kawamori, R; Yoshii, H1
Sakamoto, N; Uno, T1
Inoue, I; Ishii, J1
Bethel, MA; Feinglos, MN1
Skyler, JS1
Hunabiki, A; Kasuga, M; Morita, S1
Akuzawa, S; Ito, H; Iwaoka, K; Kamato, T; Kiso, T; Miyata, K; Nagakura, Y; Naitoh, Y; Sakai, H; Suzuki, M; Yamaguchi, T; Yamano, M; Yuki, H1
Campbell, IW1
Hirsch, IB; White, JA1
Awad, J; Schindel, B; Schindel, Y1
Arlt, W; Auchus, RJ; Miller, WL1
Feinglos, MN; Luna, B1
Rybka, J1
Drexler, AJ; Robertson, C1
Beattie, P; Harrigan, RA; Nathan, MS1
Hotta, N1
Inzucchi, SE1
Holmboe, ES1
McCormick, M; Quinn, L1
Inzucchi, SE; Mayerson, AB1
Weissman, P1
Slocum, JM; Sosa, ME1
Langer, O1
Maruyama, T1
Mori, Y; Sekihara, H1
Kitaoka, H1
Levitt, O; Merlob, P; Stahl, B1
Kotake, H1
Sakura, H1
Basu, A; Kudva, YC; Zangeneh, F1
Cai, Y; Finsi, J; Heimberg, H; Hinke, SA; Martens, GA; Pipeleers, D; Van de Casteele, M1
Frenzel, E; Niederweis, M; Schmidt, S; Steinhauer, K1
Aldahmash, AM; Alkahtani, A; Alkahtany, SM; Anil, S; Elsafadi, MA; Mahmood, A1

Reviews

28 review(s) available for thiazoles and biguanides

ArticleYear
Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
    Drugs, 1995, Volume: 50, Issue:2

    Topics: Acarbose; Aldehyde Reductase; Biguanides; Diabetes Mellitus, Type 2; Glucose; Guanidines; Humans; Hyperglycemia; Hypertension; Hypoglycemic Agents; Insulin; Lipids; Prospective Studies; Randomized Controlled Trials as Topic; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Trisaccharides; United Kingdom

1995
Oral antidiabetic drugs: an overview.
    Diabetic medicine : a journal of the British Diabetic Association, 1996, Volume: 13, Issue:9 Suppl 6

    Topics: Biguanides; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Glucose Intolerance; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Sulfonylurea Compounds; Thiazoles

1996
[Drug therapy in subjects with impaired glucose tolerance].
    Nihon rinsho. Japanese journal of clinical medicine, 1996, Volume: 54, Issue:10

    Topics: Acarbose; Biguanides; Chromans; Diabetes Mellitus, Type 2; Glucose Intolerance; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Insulin Resistance; Metformin; Pioglitazone; Risk Factors; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Trisaccharides; Troglitazone

1996
[Oral hypoglycemic agents--overview].
    Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55 Suppl

    Topics: Acarbose; Administration, Oral; Biguanides; Chromans; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Insulin Resistance; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Trisaccharides; Troglitazone

1997
[Measures to meet the side effects of the orally administered antihyperglycemic drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55 Suppl

    Topics: Acarbose; Administration, Oral; Animals; Biguanides; Cardiovascular System; Chromans; Drug Interactions; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Inositol; Insulin Resistance; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Trisaccharides; Troglitazone

1997
Treatment of type 2 diabetes mellitus.
    The Medical clinics of North America, 1998, Volume: 82, Issue:4

    Topics: Biguanides; Blood Glucose; Chromans; Diabetes Mellitus, Type 2; Diet, Diabetic; Exercise Therapy; Glycoside Hydrolase Inhibitors; Health Care Costs; Humans; Hypoglycemic Agents; Insulin; Patient Compliance; Patient Participation; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone

1998
[Etiology and therapy of insulin resistance].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1999, Sep-10, Volume: 88, Issue:9

    Topics: Animals; Arteriosclerosis; Biguanides; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Life Style; Obesity; Risk Factors; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha

1999
Antidiabetic drugs present and future: will improving insulin resistance benefit cardiovascular risk in type 2 diabetes mellitus?
    Drugs, 2000, Volume: 60, Issue:5

    Topics: Biguanides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Risk Factors; Thiazoles

2000
Nonhypoglycemic drug reactions of agents used to treat diabetes.
    Endocrinology and metabolism clinics of North America, 2000, Volume: 29, Issue:4

    Topics: Benzamides; Biguanides; Diabetes Mellitus; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazoles

2000
[Update on new oral treatment for diabetes].
    Harefuah, 2001, Volume: 140, Issue:1

    Topics: Administration, Oral; Biguanides; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Incidence; Sulfonylurea Compounds; Thiazoles

2001
Oral agents in the management of type 2 diabetes mellitus.
    American family physician, 2001, May-01, Volume: 63, Issue:9

    Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones

2001
[Current and future aspects of oral antidiabetic agents in type 2 diabetes].
    Vnitrni lekarstvi, 2001, Volume: 47, Issue:5

    Topics: Administration, Oral; Biguanides; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones

2001
Type 2 diabetes. How new insights, new drugs are changing clinical practice.
    Geriatrics, 2001, Volume: 56, Issue:6

    Topics: Acarbose; Aged; Biguanides; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Thiazoles; Thiazolidinediones; Treatment Outcome

2001
Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Annals of emergency medicine, 2001, Volume: 38, Issue:1

    Topics: Administration, Oral; Benzoates; Biguanides; Blood Glucose; Diabetes Mellitus, Type 2; Drug Interactions; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Metabolic Clearance Rate; Safety; Sulfonylurea Compounds; Thiazoles; Time Factors; Treatment Outcome

2001
[Clinical difference between thiazolidinediones and biguanides].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:11

    Topics: Biguanides; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin Resistance; Thiazoles; Thiazolidinediones

2001
Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
    JAMA, 2002, Jan-16, Volume: 287, Issue:3

    Topics: Administration, Oral; Biguanides; Blood Glucose; Carbamates; Chromans; Diabetes Mellitus, Type 2; Diet; Drug Therapy, Combination; Enzyme Inhibitors; Exercise; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Piperidines; Randomized Controlled Trials as Topic; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone

2002
Treatment of type 2 diabetes mellitus: pharmacologic intervention.
    The Journal of cardiovascular nursing, 2002, Volume: 16, Issue:2

    Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Glucosidases; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones

2002
Type 2 diabetes therapy. A pathophysiologically based approach.
    Postgraduate medicine, 2002, Volume: 111, Issue:3

    Topics: alpha-Glucosidases; Benzamides; Biguanides; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones

2002
Reappraisal of the pharmacologic approach to treatment of type 2 diabetes mellitus.
    The American journal of cardiology, 2002, Sep-05, Volume: 90, Issue:5A

    Topics: Administration, Oral; Antihypertensive Agents; Biguanides; Diabetes Mellitus, Type 2; Glucosamine; Hormone Replacement Therapy; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Insulin Resistance; Sulfonylurea Compounds; Thiazoles

2002
Use of antidiabetes agents in pregnancy: current practice and controversy.
    The Journal of perinatal & neonatal nursing, 2002, Volume: 16, Issue:2

    Topics: Administration, Oral; Benzamides; Biguanides; Diabetes, Gestational; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Male; Polycystic Ovary Syndrome; Pregnancy; Pregnancy in Diabetics; Sulfonylurea Compounds; Thiazoles

2002
When diet fails: insulin and oral hypoglycemic agents as alternatives for the management of gestational diabetes mellitus.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2002, Volume: 11, Issue:4

    Topics: Administration, Oral; Biguanides; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetes, Gestational; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Practice Guidelines as Topic; Pregnancy; Sulfonylurea Compounds; Thiazoles; Treatment Failure

2002
[Pharmacotherapies for type 1 diabetes mellitus].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 9

    Topics: Adjuvants, Immunologic; Animals; Biguanides; Chaperonin 60; Diabetes Mellitus, Type 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Islets of Langerhans; Niacinamide; Peptide Fragments; Peptides; Regeneration; Sulfonylurea Compounds; Thiazoles

2002
[Adverse effects of oral hypoglycemic agents].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 9

    Topics: Acarbose; Administration, Oral; Biguanides; Cyclohexanes; Drug Interactions; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Nateglinide; Phenylalanine; Pioglitazone; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones

2002
[Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 9

    Topics: Acarbose; Animals; Biguanides; Chromans; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Insulin Resistance; Pioglitazone; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone

2002
Oral antihyperglycemic agents during pregnancy and lactation: a review.
    Paediatric drugs, 2002, Volume: 4, Issue:11

    Topics: Administration, Oral; Biguanides; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; Lactation; Milk, Human; Pregnancy; Pregnancy in Diabetics; Pregnancy Outcome; Sulfonylurea Compounds; Thiazoles

2002
[Syndrome X].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 10

    Topics: Animals; Bezafibrate; Biguanides; Fatty Acids, Nonesterified; Humans; Hyperglycemia; Hyperinsulinism; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Leptin; Life Style; Metabolic Syndrome; Pioglitazone; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha

2002
[Combination therapy with biguanides].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 10

    Topics: Acarbose; Biguanides; Chromans; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Treatment Outcome; Troglitazone

2002
Insulin sensitizers.
    Mayo Clinic proceedings, 2003, Volume: 78, Issue:4

    Topics: Biguanides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Ligands; Thiazoles; Thiazolidinediones

2003

Other Studies

10 other study(ies) available for thiazoles and biguanides

ArticleYear
Relationship between Legionella pneumophila and Acanthamoeba polyphaga: physiological status and susceptibility to chemical inactivation.
    Applied and environmental microbiology, 1992, Volume: 58, Issue:8

    Topics: Acanthamoeba; Animals; Biguanides; Disinfectants; Drug Resistance; Iron; Legionella pneumophila; Thiazoles; Water Microbiology

1992
[Toxicology of selected biocides].
    Schriftenreihe des Vereins fur Wasser-, Boden- und Lufthygiene, 1987, Volume: 72

    Topics: Anti-Infective Agents, Local; Antifungal Agents; Biguanides; Chlorophenols; Cosmetics; Dichlorophen; Disinfectants; Hydrogen Peroxide; Oxazoles; Pharmaceutic Aids; Preservatives, Pharmaceutical; Thiazoles

1987
Hypoglycaemic activity of some substituted thiazole and thiadiazole biguanides.
    Indian journal of experimental biology, 1966, Volume: 4, Issue:3

    Topics: Animals; Biguanides; Blood Glucose; Female; Guinea Pigs; Male; Thiazoles

1966
Targeted glycemic control in type 2 diabetes.
    The Journal of the Florida Medical Association, 1998, Volume: 85, Issue:2

    Topics: Aged; Algorithms; Anti-Obesity Agents; Biguanides; Blood Glucose; Blood Glucose Self-Monitoring; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone

1998
Pharmacological profile of YM-31636, a novel 5-HT3 receptor agonist, in vitro.
    European journal of pharmacology, 2000, Dec-08, Volume: 409, Issue:2

    Topics: Acetylcholine; Action Potentials; Animals; Anthraquinones; Atrial Function; Biguanides; Binding, Competitive; Colon; Dinoprostone; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; Humans; In Vitro Techniques; Muscle Contraction; Myocardial Contraction; Pyrroles; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Receptor Agonists; Thiazoles

2000
Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase.
    The Journal of biological chemistry, 2001, May-18, Volume: 276, Issue:20

    Topics: 3-Hydroxysteroid Dehydrogenases; Biguanides; Chromans; Cloning, Molecular; Humans; Kinetics; Metformin; Pioglitazone; Recombinant Proteins; Saccharomyces cerevisiae; Steroid 17-alpha-Hydroxylase; Steroid Hydroxylases; Thiazoles; Thiazolidinediones; Troglitazone

2001
Oral antihyperglycemic therapy for type 2 diabetes: clinical applications.
    JAMA, 2002, Jan-16, Volume: 287, Issue:3

    Topics: Aged; Biguanides; Comorbidity; Decision Making; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Evidence-Based Medicine; Female; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Patient Education as Topic; Patient Participation; Physician-Patient Relations; Practice Guidelines as Topic; Sulfonylurea Compounds; Thiazoles

2002
Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer.
    British journal of pharmacology, 2007, Volume: 150, Issue:8

    Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Biguanides; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Electron Transport; Electron Transport Complex I; Electron Transport Complex II; Enzyme Activation; Glucose; Hypoglycemic Agents; Insulin-Secreting Cells; Metformin; Mice; Mitochondria; Multienzyme Complexes; NADP; Oxidation-Reduction; Phenformin; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Succinates; Tetrazolium Salts; Thiazoles; Time Factors

2007
Importance of porins for biocide efficacy against Mycobacterium smegmatis.
    Applied and environmental microbiology, 2011, Volume: 77, Issue:9

    Topics: Biguanides; Disinfectants; Gene Deletion; Imines; Microbial Viability; Mycobacterium smegmatis; Oxazines; Oxazoles; Porins; Pyridines; Staining and Labeling; Thiazoles; Triazines; Xanthenes

2011
Cytotoxicity of QMix™ endodontic irrigating solution on human bone marrow mesenchymal stem cells.
    BMC oral health, 2014, Mar-29, Volume: 14

    Topics: Acridine Orange; Biguanides; Cell Culture Techniques; Cell Death; Cell Line; Cell Membrane; Cell Shape; Cell Survival; Coloring Agents; Ethidium; Fluorescent Dyes; Humans; Mesenchymal Stem Cells; Microscopy, Electron, Scanning; Oxazines; Polymers; Root Canal Irrigants; Sodium Hypochlorite; Tetrazolium Salts; Thiazoles; Time Factors; Xanthenes

2014